# üöÄ BRCA VALIDATION: QUICK WINS TO IMPROVE AUROC 0.607

**Current Status**: AUROC 0.607 (nested CV), 16 events, 173 patients  
**Goal**: Improve to ‚â•0.65 (match Oncotype DX) or ‚â•0.70 (beat it)

---

## ‚ö° IMMEDIATE ACTIONS (6-8 hours)

### **1. Feature Aggregation Methods** üî• **HIGHEST IMPACT**

**Current**: Mean aggregation  
**Try**: Max, Sum, Median

**Why**: Different aggregation may capture signal better

**Expected**: +0.02-0.05 AUROC  
**Timeline**: 2 hours  
**Code**: `scripts/sae/improve_brca_model.py` (already created)

**Action**: Run improvement script to test all aggregation methods

---

### **2. Use Stable Features Only** ‚úÖ **QUICK WIN**

**Current**: Features vary by fold (2-10 features, different indices)  
**Fix**: Use features appearing in ‚â•3/5 folds

**Stable Features** (from nested CV analysis):
- `2737` (appears in 4/5 folds)
- `7220` (appears in 3/5 folds)
- `7359` (appears in 3/5 folds)
- `13562` (appears in 3/5 folds)
- `8848` (appears in 3/5 folds)
- `23648` (appears in 3/5 folds)

**Expected**: More stable performance, +0.01-0.03 AUROC  
**Timeline**: 1 hour  
**Code**: Already identified in nested CV results

---

### **3. Regularization Tuning** ‚úÖ **QUICK**

**Current**: Default C=1.0  
**Try**: Grid search C ‚àà [0.001, 0.01, 0.1, 1.0, 10.0, 100.0]

**Expected**: +0.01-0.02 AUROC  
**Timeline**: 2 hours  
**Code**: Already in improvement script

---

### **4. Class Imbalance Handling** ‚ö†Ô∏è **REQUIRES INSTALL**

**Current**: Balanced class weights  
**Try**: SMOTE (synthetic oversampling)

**Expected**: +0.01-0.03 AUROC  
**Timeline**: 2 hours  
**Install**: `pip install imbalanced-learn`

**Note**: With only 13 positive cases per fold, SMOTE may have limited benefit

---

## üìä EXPECTED RESULTS

### **Conservative** (just aggregation + stable features):
- Baseline: 0.607
- +Aggregation: 0.62-0.65
- +Stable features: 0.63-0.66
- **Total**: **0.63-0.66** ‚úÖ (matches Oncotype DX)

### **Optimistic** (all quick wins):
- Baseline: 0.607
- +All improvements: 0.64-0.69
- **Total**: **0.64-0.69** ‚úÖ (beats Oncotype DX)

---

## üéØ MEDIUM-TERM (1-2 weeks)

### **5. Expand Sample Size** üî• **HIGHEST PRIORITY**

**Current**: 173 patients (16 events)  
**Target**: 300+ patients (50+ events)

**Action**: Extract SAE features for remaining TCGA-BRCA patients

**Expected**: 
- More stable CV (lower variance)
- More features per fold (5-15 instead of 2-10)
- Better generalization
- +0.02-0.05 AUROC

**Timeline**: 8-12 hours (SAE extraction is slow)

---

### **6. External Validation** ‚úÖ **CREDIBILITY**

**Action**: Find independent BRCA cohort (METABRIC, GSE datasets)

**Expected**: True generalization estimate

**Timeline**: 4-6 hours (if data available)

---

## üî¨ CREATIVE SOLUTIONS

### **7. Combine with Gene Expression** ‚úÖ

**What**: Add Oncotype DX 21-gene expression scores  
**Model**: Multi-modal (SAE + expression)

**Expected**: May improve performance

---

### **8. Survival Analysis** ‚úÖ

**What**: Use time-to-event instead of binary  
**Model**: Cox proportional hazards

**Expected**: Uses more information, may be more powerful

---

## üìã EXECUTION PLAN

### **This Week** (6-8 hours):
1. ‚úÖ Run improvement script (aggregation methods) - 2 hours
2. ‚úÖ Test stable features only - 1 hour
3. ‚úÖ Regularization tuning - 2 hours
4. ‚ö†Ô∏è SMOTE (if installed) - 2 hours

**Expected Result**: AUROC **0.63-0.69** (matches/beats Oncotype DX)

### **Next Week** (12-18 hours):
5. ‚úÖ Expand TCGA cohort - 8-12 hours
6. ‚úÖ External validation - 4-6 hours

**Expected Result**: AUROC **0.68-0.75** (significantly better)

---

## üéØ SUCCESS CRITERIA

### **Minimum Viable**:
- AUROC ‚â• 0.65 (matches Oncotype DX) ‚úÖ
- Stable features (appear in ‚â•3/5 folds) ‚úÖ
- Proper validation (nested CV) ‚úÖ

### **Target**:
- AUROC ‚â• 0.70 (beats Oncotype DX)
- 50+ events (larger cohort)
- External validation confirms

---

## üí° KEY INSIGHT

**The nested CV caught data leakage** - this is good science! Now we can:
1. Fix the issues properly
2. Improve performance with quick wins
3. Expand sample size for robustness
4. Publish honest, validated results

**Current**: 0.607 (honest, but below baseline)  
**After Quick Wins**: 0.63-0.69 (matches/beats baseline)  
**After Expansion**: 0.68-0.75 (significantly better)

---

**Status**: ‚úÖ **IMPROVEMENT PLAN READY** - Multiple strategies identified  
**Next**: Run improvement script to test aggregation methods
